Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients
- PMID: 23062225
- DOI: 10.1016/j.eururo.2012.09.062
Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients
Comment on
-
A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer.Eur Urol. 2013 Feb;63(2):189-97. doi: 10.1016/j.eururo.2012.09.008. Epub 2012 Sep 13. Eur Urol. 2013. PMID: 23000088 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous